SC
TEVA icon

Schulhoff & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Schulhoff & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,609
Closed -$206K – 107
2018
Q3 		$206K Hold
9,609
– – 0.12% 104
2018
Q2 		$233K Sell
9,609
-1,500
-14% -$30.6K 0.14% 99
2018
Q1 		$189K Hold
11,109
– – 0.11% 105
2017
Q4 		$210K Buy
11,109
+2
+0% +$30 0.12% 103
2017
Q3 		$195K Buy
11,107
+2
+0% +$45 0.12% 101
2017
Q2 		$368K Sell
11,105
-496
-4% -$15.4K 0.22% 76
2017
Q1 		$372K Buy
11,601
+1,004
+9% +$34.3K 0.23% 76
2016
Q4 		$384K Buy
10,597
+104
+1% +$4.15K 0.24% 74
2016
Q3 		$482K Sell
10,493
-98
-0.9% -$5.11K 0.3% 65
2016
Q2 		$531K Buy
10,591
+2
+0% +$106 0.33% 61
2016
Q1 		$566K Buy
10,589
+3
+0% +$176 0.37% 53
2015
Q4 		$694K Buy
10,586
+2
+0% +$124 0.47% 48
2015
Q3 		$597K Sell
10,584
-298
-3% -$19.3K 0.43% 52
2015
Q2 		$643K Sell
10,882
-496
-4% -$30.6K 0.41% 51
2015
Q1 		$708K Hold
11,378
– – 0.44% 49
2014
Q4 		$654K Buy
11,378
+2
+0% +$111 0.39% 50
2014
Q3 		$611K Buy
11,376
+2
+0% +$106 0.38% 55
2014
Q2 		$596K Buy
11,374
+2,677
+31% +$137K 0.37% 57
2014
Q1 		$460K Buy
8,697
+3
+0% +$139 0.31% 59
2013
Q4 		$348K Sell
8,694
-398
-4% -$15.7K 0.24% 76
2013
Q3 		$343K Buy
9,092
+378
+4% +$14.7K 0.25% 66
2013
Q2 		$342K Buy
+8,714
New +$339K 0.26% 64

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Schulhoff & Co's TEVA Position: Q4 2018 in Review

Schulhoff & Co sold out of Teva Pharmaceuticals (TEVA) in Q4 2018, closing a stake of 9,609 shares — an estimated $206K sold.

Schulhoff & Co first reported a position in TEVA in Q2 2013 and held it in 22 quarters. The position peaked at $708K in Q1 2015. 551 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

  • Schulhoff & Co reported no remaining Teva Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Schulhoff & Co sold 9,609 Teva Pharmaceuticals shares in Q4 2018, an estimated $206K.
  • Schulhoff & Co first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Schulhoff & Co's Teva Pharmaceuticals position peaked at $708K in Q1 2015.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on Schulhoff & Co's 13F filing for Q4 2018, filed 7 Feb 2019.